baber/WOPTO huggingface dataset:
Patent EP-4208649-A1 (EP)
Inventor: ECHLE BENJAMIN
IPC: F16B25/00
Filed: 2021-08-17
Abstract: Die Erfindung betrifft eine Betonschraube (1) zum Einschrauben in ein Bohrloch (2) in einem Bauteil (3) aus Beton. Auf einem Grundkörper (5) der Betonschraube (1) ist eine erste, metallische Korrosionsschutzschicht und auf dieser Korrosionsschutzschicht eine zweite, organische Korrosionsschutzschicht angeordnet. Erfindungsgemäß ist in einer Matrix der zweiten, organischen Korrosionsschutzschicht ein reibungsminderndes Schmiermittel enthalten.
Patent EP-4173017-A1 (EP)
Inventor: GRÜNLER ROBERT
IPC: H01H33/66
Filed: 2021-09-03
Abstract: Die Erfindung betrifft einen Hochspannungsleistungsschalter (1) und ein Verfahren zum Herstellen des Hochspannungsleistungsschalters (1), mit wenigstens einer Vakuumschaltröhre (2), welche durch wenigstens eine Halterung (5, 6) des Hochspannungsleistungsschalters (1) gelagert ist, wobei die Vakuumschaltröhre (2) wenigstes zwei Kontaktstücke (3, 4) umfasst, welche mit der wenigstens einen Halterung (5, 6) verbunden sind. Wenigstens ein Kontaktstück (3, 4) ist mit der wenigstens einen Halterung (5, 6) über eine Kontakthülse (9) verbunden.
Patent EP-4132208-A1 (EP)
Inventor: KWON KI BUM
IPC: H04L1/18
Filed: 2021-03-10
Abstract: The present disclosure relates to a method and apparatus for discontinuous reception (DRX) for a link between a network and a user equipment (UE) based on device-to-device (D2D) communication in a wireless communication system. A method for DRX of a first UE in a wireless communication system according to an example embodiment of the present disclosure may include receiving, from a second UE, hybrid automatic repeat request (HARQ) feedback information related to sidelink data transmitted from the first UE; transmitting, by the first UE, HARQ NACK information to a base station in an uplink based on the HARQ feedback information from the second UE; sleeping during an operation of the first timer that starts after the first UE transmits the HARQ NACK information; and monitoring a downlink control channel that includes resource allocation information on a sidelink data retransmission during an operation of a second timer that starts after the first timer expires.
Patent EP-4210817-A1 (EP)
Inventor: HENSCHEL MARK E
IPC: A61N1/375
Filed: 2021-09-08
Abstract: Various embodiments of an electronic package and an implantable medical device that includes such package are disclosed. The electronic package includes a monolithic package substrate having a first major surface and a second major surface, an integrated circuit disposed in an active region of the package substrate, and a conductive via disposed through an inactive region of the package substrate and extending between the first major surface and the second major surface of the package substrate. The conductive via is separated from the active region by a portion of the inactive region of the substrate.
Patent EP-4129416-A1 (EP)
Inventor: IIDA MASAYUKI
IPC: A61Q19/08
Filed: 2021-03-22
Abstract: A composition for external preparation for skin containing the following components (A), (B), and (C):(A) from 1 to 30 mass% of a polymer having a silicone moiety in which a ratio of deformation measured by a predetermined method (1) is 0.3 or higher and 1 or lower, and in a bend resistance test using a cylindrical mandrel method performed by a predetermined method (2), a minimum diameter of a cylindrical mandrel which causes no cracks in the polymer film is 2 mm or longer and 25 mm or shorter,(B) a volatile oil having a volatilization rate of 14% or higher after drying at 1 atmosphere, 40°C, and R.H. of 60% for 30 minutes, and(C) a cation-modified clay mineral,wherein a mass ratio of the component (A) to the component (C), (A)/(C), is from 5 to 23.
Patent EP-4222413-A1 (EP)
Inventor: JANKI ZOLTÁN
IPC: F21S8/08
Filed: 2021-09-24
Abstract: Angle adjustment and rotation system (1) comprising: a first element (100) attachable to a luminaire pole (11), and comprising a tubular portion (110) along a first axis (A1); a second element (200) attachable to a luminaire head (12), a pivot element (300), and a locking element (400); the second element is coupled to an end of the tubular portion (110); one of the second and first element is provided with an edge portion (211); the first and second element and the pivot element (300) enable a rotation movement around a pivot axis (A3) perpendicular to the first axis (A1); the locking element (400) comprises an engagement portion (411) configured not to be in contact with the edge portion (211) in a first state, and to cooperate with the edge portion (211) in a plurality of second states.
Patent EP-4225151-A1 (EP)
Title: End cap for biological sample collection device and collection device comprising same
Inventor: SAGAS PIERRE
IPC: A61B10/00
Filed: 2021-10-08
Abstract: The present invention relates to a cap for a biological sample collection device, the device comprising a collection receptacle (1) and a swab (2) for collecting a biological sample, the cap (3) comprising: - a cover (31) for capping the receptacle (1) - an internal element (32) projecting from the cover (31) and comprising at least first and second complementary clamping members (321, 322), the application of a pinch force to the cap (3) causing the free ends of the first and second clamping members (321, 322) to move towards each other.
Patent EP-4139981-A1 (EP)
Title: Batteries à flux redox organiques à base de carbénium
Inventor: GIANETTI THOMAS
IPC: C07D279/30
Filed: 2021-04-23
Abstract: L'invention concerne une batterie à flux redox comprenant : un catholyte comprenant un dication radicalaire d'un composé carbénium hétérocyclique conjugué ; et un anolyte comprenant un radical neutre d'un composé carbénium hétérocyclique conjugué ; les composés carbénium hétérocycliques conjugués présents dans le catholyte et l'anolyte étant le même composé ; et la batterie à flux redox a un potentiel de circuit ouvert supérieur à environ 2 V. Une batterie à flux redox comprenant : un catholyte comprenant un composé cationique hétérocyclique conjugué dans un premier état d'oxydation ; et un anolyte comprenant un composé cationique hétérocyclique conjugué dans un second état d'oxydation ; le premier état d'oxydation étant un état d'oxydation plus élevé que le second état d'oxydation.
Patent EP-4222537-A1 (EP)
Title: Method and apparatus for implementing a signature finder
Inventor: ROY ATISH
IPC: G01V1/30
Filed: 2021-09-22
Abstract: Techniques to match a signature in seismic data with a seismic attribute space. A method includes automatically selecting a first plurality of seismic attributes corresponding to seismic data as first selected seismic attributes, combining the first selected seismic attributes into a first realization of attributes, performing a first cluster analysis on the first realization of attributes to generate a first clustered volume, selecting a region of interest (ROI) in the seismic data, projecting the ROI onto the first clustered volume to generate a first signature, determining a first level of correlation between the ROI and the first signature, and determining whether the first level of correlation between the ROI and the first signature exceeds a predetermined threshold and outputting a first correlation volume corresponding to the first signature when the first level of correlation between the ROI and the first signature exceeds the predetermined threshold.
Patent EP-4150540-A1 (EP)
Inventor: PATEL BHAVIK
IPC: G06Q20/06
Filed: 2021-05-12
Abstract: A system for automated manipulation resistant indexing is disclosed. The system may be configured to calculate a total prefilter trade volume of an historical trade data set based on a lookback coefficient, wherein the historical trade data set associated with a prefiltered exchange set, calculate a composition percentage of the total prefilter volume for each element of the prefiltered exchange set, apply a first filtering function based on the composition percentage to the prefiltered exchange set to generate a first filtered exchange set, normalize the first filtered exchange set based on the total prefilter trade volume to generate a first normalized exchange set, and generate a first weighting function based on the first normalized exchange set.
Patent EP-4152097-A1 (EP)
Inventor: URAKAMI Hideyuki
IPC: G03F7/20
Filed: 2021-03-09
Abstract: An extreme ultraviolet light source apparatus includes a cathode, an anode, an electric power supply, a first support structure made of metal for supporting the cathode, and a second support structure made of metal for supporting the anode. The electric power supply causes a discharge between the cathode and anode for generating a plasma that emits extreme ultraviolet light. The cathode is connected to the first rotational shaft made of metal, and the anode is connected to the second rotational shaft made of metal. The first support structure has a first support wall portion and a first tubular portion that surrounds the first rotational shaft. The second support structure has a second support wall portion and a second tubular portion that surrounds the second rotational shaft. The first and second support wall portions overlap each other. The first support wall portion has a through-hole through which the second tubular portion is inserted, or the second support wall portion has a through-hole through which the first tubular portion is inserted.
Patent EP-4252302-A1 (EP)
Title: Festkörperzelle und zugehöriges herstellungsverfahren
Inventor: MA QIANLI
IPC: H01M10/054
Filed: 2021-10-28
Abstract: Die Erfindung betrifft eine Festkörperzelle, eine Festkörperbatterie und ein zugehöriges Verfahren zur Herstellung einer Festkörperzelle. Eine Festkörperzelle (10) hat einen Elektrolyten (20), der NaSICON umfasst. Die Festkörperzelle (10) umfasst eine an einem ersten Bereich (21) des Elektrolyten (20) angeordnete erste Elektrode (12) und eine an einem zweiten Bereich (22) des Elektrolyten (20) angeordnete zweite Elektrode (14). An zumindest einem dritten Bereich (23) des Elektrolyten (20) auf einer äußeren Oberfläche (25) des Elektrolyten (20) ist eine durchgehende Materialschicht (30) angeordnet. Alternativ ist eine chemische Zusammensetzung der äußeren Oberfläche (25) in dem dritten Bereich (23) des Elektrolyten (20) verändert. Auf diese Weise kann effektiv die Bildung von Filamenten bzw. Dendriten verhindert werden und ein Betrieb bei deutlich erhöhten Stromdichten ist möglich.
Patent EP-4238070-A1 (EP)
Inventor: HERLITZIUS THOMAS
IPC: G06V20/40
Filed: 2021-11-01
Abstract: Die Erfindung betrifft Computerimplementiertes Verfahren zur optischen Erfassung, zur Erkennung und zur Quantifizierung von relevanten Zuständen und/oder deren Änderungen an mindestens einem Zielobjekt wobei mindestens ein Zielobjekt gegenüber einer optischen Sensoreinrichtung temporär angeordnet ist und wobei die Fehlerzustände der Fehlerklassen vom Optimalzustand abweichend sind. Das Verfahren ist besonders dadurch gekennzeichnet, dass die Unterscheidung von Hintergrund und Zielobjekt durch eine höhere Änderungsrate der Bildinformationen des Hintergrundes gegenüber Änderungsrate der Bildinformationen des Zielobjektes erfolgt.
Patent EP-4237574-A1 (EP)
Inventor: HOUSTON PETER LOUIS
IPC: C12P23/00
Filed: 2021-11-01
Abstract: La présente invention concerne la production fermentative de rétinoïdes, contenant du rétinol ou de l'acétate de rétinyle, comprenant la culture d'une cellule hôte produisant un rétinoïde, telle qu'une cellule hôte fongique, en particulier un hôte oléagineux tel que, par exemple, Yarrowia, dans un système de culture à deux phases en présence d'huile végétale en tant que seconde phase. Les rétinoïdes présents dans l'huile végétale peuvent être utilisés sans autres étapes d'isolation ou de purification en tant que principes actifs dans l'industrie alimentaire, alimentaire animale, pharmaceutique ou cosmétique.
Patent EP-4244215-A1 (EP)
Inventor: VERGUNST FRANK
IPC: C07D317/36
Filed: 2021-11-10
Abstract: The invention is directed to a process to continuously react a gaseous mixture of an epoxide compound and carbon dioxide in the presence of a heterogeneous catalyst at a pressure of between 0.1 and 0.4 MPa in one or more reactors to a liquid cyclic carbonate product and a gaseous effluent stream comprising unreacted epoxide compound and carbon dioxide. Part of the gaseous effluent is purged from the process and another part of the gaseous effluent is fed to an ejector where the gaseous effluent mixes with a gaseous mixture of epoxide compound and carbon dioxide having a pressure which is at least more than 0.3 MPa higher than the pressure of the gaseous effluent. The obtained ejector effluent is fed to the one or more reactors.
Patent EP-4244111-A1 (EP)
Inventor: EMANUEL JOHN
IPC: B61B13/00
Filed: 2021-11-08
Abstract: A vehicle is configured to operate in a first mode in a cantilevered manner from a left side of the vehicle; in a second mode in a cantilevered manner from a right side of the vehicle; and in a third mode in which the vehicle is supported from beneath in a non-cantilevered manner. The vehicle comprises a number of wheel assemblies to facilitate operation in first, second and third modes. The vehicle is configured to navigate between first mode and second mode at junctions offering both options by electing different combinations of wheel engagement and disengagement.
Patent EP-4157275-A1 (EP)
Inventor: HUNT HAZEL
IPC: A61K31/4745
Filed: 2021-05-26
Abstract: Relacorilant is useful in the treatment of cancer and hypercortisolism. Many drugs useful in treating cancer or hypercortisolism are metabolized by CYP2C8 enzymes. The effects of concomitant administration of relacorilant and a CYP2C8 substrate are disclosed herein. Relacorilant potently inhibited CYP2C8 in an  in vitro  test, indicating that co-administration of relacorilant and a CYP2C8 substrate would be expected to increase the CYP2C8 substrate plasma exposure more than five-fold  in vivo . Significant reductions in CYP2C8 substrate doses would be expected to be required when administered with relacorilant. Surprisingly, no such increase in plasma exposure was seen in human studies. Applicant discloses that relacorilant may be safely co-administered with unmodified doses of CYP2C8 substrates such as pioglitazone, rosiglitazone, and enzalutamide. Relacorilant and unmodified doses of enzalutamide may be co-administered to treat cancer, e.g., prostate cancer. Relacorilant and unmodified doses of pioglitazone or rosiglitazone may be co-administered to treat cancer or hypercortisolism.
Patent EP-4158040-A1 (EP)
Title: Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
Inventor: WRIGHT JASON BOKE
IPC: C12N15/90
Filed: 2021-05-27
Abstract: Provided herein are recombinant adeno-associated virus (rAAV) compositions that can restore phenylalanine hydroxylase (PAH) gene function in cells, and methods for using the same to treat diseases associated with reduction of PAH gene function ( e.g ., PKU). Also provided are nucleic acids, vectors, packaging systems, and methods for making the adeno-associated virus compositions.
Patent EP-4159672-A1 (EP)
Inventor: KAMATA TOMOYA
IPC: C25B1/02
Filed: 2021-04-06
Abstract: A hydrogen system includes: a compressor that includes an anode, a cathode, and an electrolyte membrane interposed therebetween and generates compressed hydrogen by applying a voltage between the anode and the cathode to move protons extracted from anode fluid supplied to the anode to the cathode; a voltage applicator that applies the voltage between the anode and the cathode; a first flow passage through which a cathode off-gas containing the compressed hydrogen discharged from the cathode is supplied to the anode of the compressor; a first on-off valve disposed in the first flow passage; and a controller that causes the voltage applicator to apply the voltage with the first on-off valve opened during a period of time from startup of the hydrogen system until supply of the cathode off-gas to a hydrogen reservoir is started.
Patent EP-4240735-A1 (EP)
Title: Crystalline forms of piperazine-1,4-diylbis((6-(1h-benzoi[d]imidazo-2-yl)pyridin-2yl)methanone) as lancl2 modulators
Inventor: BASSAGANYA-RIERA JOSEP
IPC: C07D401/14
Filed: 2021-11-02
Abstract: Crystalline forms of piperazine-1,4-diylbis((6-(1 H -benzo[ d ]imidazo-2-yl)pyridine-2- yl)methanone), compositions containing one or more crystalline forms of piperazine- 1,4-diylbis((6-(1 H -benzo[ d ]imidazo-2-yl)pyridine-2-yl)methanone), processes for preparing crystalline forms of piperazine-1,4-diylbis((6-(1 H -benzo[ d ]imidazo-2-yl)pyridine-2- yl)methanone), and methods of using crystalline forms of piperazine- 1,4-diylbis((6-(1 H -benzo[ d ]imidazo-2-yl)pyridine-2-yl)methanone).
Patent EP-4162668-A1 (EP)
Title: A network monitoring device, and applications thereof
Inventor: WATSON JOHN
IPC: H04L12/26
Filed: 2021-06-03
Abstract: A key broker monitors network traffic metadata and determines which decryption keys are required at one or more packet brokers in order to decrypt relevant traffic required by various network monitoring devices. The key broker retrieves the required keys from a secure keystore distributes them, as needed, to the network packet brokers, and dynamically updates the decryption keys stored in the network packet brokers in response to changes in network traffic.
Patent EP-4163371-A1 (EP)
Inventor: FU DONGKE
IPC: C12N15/10
Filed: 2021-05-31
Abstract: Disclosed is a nucleic acid extraction method. By using a quaternary ammonium salt, nucleic acid molecules in a solution are adsorbed to adsorbing materials such as silicon beads, magnetic beads, diatomite or silica gel or precipitated, thereby improving efficiency of nucleic acid purification and recovery.
Patent EP-4157316-A1 (EP)
Title: Methods related to the treatment of iga nephropathy
Inventor: WAX STEPHEN DANIEL
IPC: A61K38/17
Filed: 2021-06-01
Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgAl level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgAl level and the proteinuria in a patient having IgA nephropathy, and further related disclosure. Agents used in these methods are transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI)- immunoglobulin (Ig) fusion molecules (TACl-Ig/TACI-Fc fusion molecules) such as atacicept.
Patent EP-4172081-A1 (EP)
Inventor: BOSBOOM JEROEN
IPC: B65G47/74
Filed: 2021-06-25
Abstract: An apparatus, system and method for providing a clamping system for a part associated with a pallet. The apparatus, system and method may include: two opposing jaws on the pallet, each comprising a gripper for gripping the part, and a jaw base. The jaw base may include: gearing that synchronizes actuation of the opposing jaws; and a roller distal from the gripper. The part-clamp may also include: a centering spring that compresses to put pressure against the other of the opposing jaws; and a cam off the pallet, comprising a cam shaft that drives a cam face into the rollers to actuate the two grippers.
Patent EP-4175947-A1 (EP)
Title: Quinazoline compounds, preparation methods and uses thereof
Inventor: DAI XING
IPC: C07D239/72
Filed: 2021-06-30
Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I), Formula (II), or Formula (III), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS  G12D  in a cancer cell, and/or in treating various cancer such as pancreatic cancer, colorectal cancer, lung cancer or endometrial cancer.
Patent EP-4175873-A1 (EP)
Title: A hydrofoil boat
Inventor: HASSELSKOG GUSTAV
IPC: B63B1/24
Filed: 2021-07-02
Abstract: The invention involves a boat comprising - a hull (2), - a first hydrofoil (301) fastened to the hull (2) by means of a first fastening arrangement (302), and - a second hydrofoil (601) fastened to the hull (2) by means of a second fastening arrangement (503) which is separate from the first fastening arrangement (302), - wherein the second fastening arrangement comprises a strut (503) arranged to extend at least partly downwards from the hull (2), the second hydrofoil being fixed to the strut, - wherein that the boat comprises a motor pod (502) fixed to the strut (503), - wherein the strut and the motor pod are turnable in relation to the hull for steering the boat, - wherein the motor pod comprises a casing, a power supply assembly housed in the casing, and two propellers arranged to be driven by the power supply assembly, - wherein the propellers (5011, 5012) are counter-rotating.
Patent EP-4255450-A1 (EP)
Inventor: SCHECTER JORDAN MARK
IPC: A61K35/17
Filed: 2021-12-03
Abstract: L'invention concerne une méthode de traitement d'un sujet atteint d'un myélome multiple. Une seule perfusion de cellules T du récepteur antigénique chimérique (CAR) -T comprenant un CAR anti-BCMA comprenant un polypeptide est administrée au sujet. Dans certains modes de réalisation, la dose des cellules CAR-T administrées au sujet est de 1.0 x 10 5 à 5.0 x 10 6 de cellules CAR-T par kilogramme de la masse du sujet. La méthode de traitement est efficace pour obtenir et maintenir un état de négativité de la maladie résiduelle minimale, ainsi que d'autres résultats cliniques bénéfiques liés à l'efficacité et à la sûreté.
Patent EP-4248189-A1 (EP)
Inventor: CATTERALL HANNAH BETH
IPC: G01N11/02
Filed: 2021-11-23
Abstract: Methods and systems for determining a viscosity of liquid samples are provided. The methods and systems utilize an acoustic liquid handler (101). The acoustic liquid handler (101) has a first location (105) adapted to receive a liquid sample. The acoustic liquid handler (101) is configured to apply one or more acoustic signals (217) to the liquid sample in the first location (105) until a specified amount of the liquid sample has been transferred from the first location to a second location (109) of the acoustic liquid handler (101). The acoustic liquid handler (101) has a controller (202) configured to determine the viscosity of the liquid sample based on a number of acoustic signals (217) required to transfer the specified amount of the liquid sample from the first location (105) to the second location (109).
Patent EP-4182567-A1 (EP)
Title: Levitation fuse device
Inventor: SULLIVAN DANIEL
IPC: H01H77/10
Filed: 2021-07-21
Abstract: Fuse devices and electrical systems using the fuse devices are disclosed, with the fuse devices having internal components to cause a fuse blown event when the pre-determined current level is reached through the contacts. The internal components can comprise a levitation actuator that causes separation between one or more of the contacts as the current level approaches the predetermined level. This causes contact levitation and arcing, which increases the resistance at the contact being separated. This in turn causes the current through the contacts to seek another path that in the embodiments herein is a path to a pyro feature. The current activates the pyro feature, which causes the contacts to separate and puts the fuse device in "fuse blown" condition where currents can no longer flow through the contacts.